ASNC-ACC-Letter-to-Congress_Price-Transparency-Legislation_02-01-2024
In February 2024, ASNC and the American College of Cardiology shared with Senate leaders concerns about the implications of Section 4 of S.3458, the Health Care PRICE Transparency Act 2.0, which posed an unnecessary administrative burden on already strained physician practices and would not have resulted in a patient-centric solution to price transparency. Section 4 would likely have impacted the vast majority of physicians, ranging from small family practices to specialists—all of whom provide imaging services in the office setting.
Resource Type
Health Policy Memos
Related Resources
PET Case: Role of PET/CT Myocardial Perfusion Imaging in Post-Surgical Evaluation and Management of ALCAPA
Case summary: This case highlights the utility of PET myocardial perfusion imaging…
Ready for PET: Clinical Value of Cardiac PET
This content is an exclusive benefit for ASNC members. If you’re an…
How to Start a Rb-82 Cardiac PET Program: A Success Story from the UK
This content is an exclusive benefit for ASNC members. If you’re an…